Delivery Order SPE2DB20D3303-SPE2DB25FZ2U1
Award Date
3/10/25
Potential Completion Date
3/11/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3104|SPE2DB25FV5R7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,982.13 firm fixed-price delivery order contract is for the provision of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,836.54, is a Firm Fixed Price Delivery Order for the supply of ELIQUIS 5 MG TABLET 60S. The contract has an ultimate completion date of March 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,857.88 firm fixed-price delivery order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a medication used for the treatment of various medical conditions. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,148.76 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG tablets. The contract has an ultimate completion date of July 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,281.35 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,626.00 Firm Fixed Price Delivery Order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a medication used for various medical conditions. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB22D2214|SPE2DB25FS3GX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,653.85 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTCX5, was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,136.50 firm fixed-price delivery order contract is for the provision of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract is not designated with a set-aside and has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,965.60 firm-fixed-price delivery order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of January 2, 2025 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,638.81 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...